Clinical trial Recruiting at 1 site Observational Ages 18 and up

Building a short video and audio database of cancer pain to help AI recognize patient pain

Official title: SENSAI: Seeing, hEaring, seNsing: Smart, Effortless and Objective Pain Assessment With Mobile AI Technology - DataBase Development

Run by Erasmus Medical Center · NCT07262632 · Data updated 2026-11-12

This project collects short face and voice recordings from adults with cancer who do and don't have pain to help test AI that tries to recognize pain from expressions.

More Artificial Intelligence (AI) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorErasmus Medical Center
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Rotterdam, South Holland)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedMarch 11, 2026
Trial IDNCT07262632 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) with active cancer who can communicate in Dutch or English and are admitted to Erasmus MC either for cancer-related pain or for chemotherapy with no pain are the intended participants.

Probably not a fit

Patients with conditions that impair facial expression or speech (for example facial paralysis, tracheostomy, severe speech impairment), those in critical or end-of-life care, or those experiencing non-cancer pain are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, single-centre project at the Erasmus MC Cancer Institute will collect short (up to 60 seconds) video and audio recordings of adults with active cancer in two groups: patients admitted for cancer-related pain and controls admitted for chemotherapy with no pain. Participants will read a neutral prompt and, when relevant, briefly describe their pain while also completing a short questionnaire and allowing researchers to extract clinical data such as pain scores, medications, and tumour type. Recordings and linked clinical data will be securely stored under GDPR-compliant procedures and used to extract facial and vocal features with open-source tools like OpenFace and OpenSmile. The resulting labeled multimodal database is intended to support future development and testing of AI-based automatic pain recognition tools.

Why it matters

Potential benefit: If successful, this work could enable AI tools that detect pain from facial and vocal cues, helping clinicians identify and treat pain more quickly, especially when patients cannot communicate well.

How similar studies have gone: Facial and vocal feature–based approaches have shown promise in other pain and clinical settings, but applying these methods specifically to cancer-related pain is still novel and not yet validated.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients (≥18 years)
* Diagnosed with cancer, active
* Able to communicate verbally in Dutch or English
* Able to provide written informed consent.
* Pain group specific:
* Experiencing pain related to cancer
* Admitted to the hospital due to pain
* Control group specific:
* Not experiencing pain (NRS = 0)
* Admitted to the hospital for chemotherapy

Exclusion Criteria:

* Cognitive, physical, or medical limitations that prevent participation in the audiovisual recording sessions or affect facial expressions or voice (e.g. facial paralysis, tracheostomy, severe speech impairment).
* Critical illness or end-of-life care where participation would impose an additional burden.
* Experiencing pain not associated with cancer
* Infectious isolation precautions that prevent safe data collection

Where it's running

  • Erasmus University Medical Centre
    Rotterdam, South Holland, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.